Chapters

Transcript

Video

ESMO26: Paolo Tarantino, MD on ADC Resistance in Breast Cancer

Paolo Tarantino, MD, of Dana-Farber Cancer Institute, shows that antibody-drug conjugate (ADC) resistance appears to be driven by complex molecular adaptations beyond target modulation.

Published

November 3, 2026

Created by

Dana-Farber